Key facts
- This page summarizes IAF, LLC's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2024, 17:59.
IAF, LLC - 29 Dec 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- Member of 10% owner group
- Issuer ticker
- N/A
- Reported as of
- 29 Dec 2023
- Net transaction value
- +$210,000
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2024, 17:59:14 UTC
- Prior SEC filing
- 05 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward Bennett, Authorized Signatory for IAF, LLC
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
IAF, LLC filed Form 4 for Comera Life Sciences Holdings, Inc. on 05 Jan 2024.
Change
- Previous filing in this sequence was filed on 05 Jan 2024.
- Current net transaction value: +$210,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMRA
transaction
Derivative
12.0% Senior Secured Convertible Notes
Purchase
- Transaction value
- $210,000
- Shares
- Change %
- Price
- Shares after
- $210,000
- Date
- 29 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,818,181
- Exercise price
- $0.0550
- Footnotes
- F1
CMRA
transaction
Derivative
Warrants to Purchase Common Stock
Purchase
- Transaction value
- $0
- Shares
- +7,636,362
- Change %
- Price
- $0.000000
- Shares after
- 7,636,362
- Date
- 29 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,636,362
- Exercise price
- $0.0550
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $210,000 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 7,636,362 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.